Role of low molecular weight heparins in prophylaxis of thromboembolic events on oncological patients with indwelling central venous catheter;Heparinas de bajo peso molecular en la profilaxis de episodios tromboembólicos en pacientes con cáncer portadores de catéter venoso central

Medicina Clinica

Volumn 133, Issue 10, 2009, Pages 365-370

  Calderero Aragón, Verónica ^a   De Gregorio Ariza, Miguel Ángel ^b   Pazo Cid, Roberto ^a   Puértolas Hernández, Teresa ^a   Lostalé Latorre, Fernando ^b   Artal Cortés, Ángel ^a   Antón Torres, Antonio ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Central venous catheter; Low weight heparin; Thromboembolic disease

Indexed keywords

BEMIPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; COLORECTAL CANCER; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; OVARY CANCER; PHLEBOGRAPHY; PROTHROMBIN TIME; RADIOLOGICAL PARAMETERS; RISK FACTOR; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM;

ADULT; AGED; ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYPERTENSION; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; NEOPLASMS; OVERWEIGHT; PHLEBOGRAPHY; PROTHROMBIN TIME; PULMONARY EMBOLISM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STATISTICS, NONPARAMETRIC; THROMBOEMBOLISM; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER;

EID: 69949138571     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.05.015     Document Type: Article

References (22)

1. J.A. Heit Venous thromboembolism epydemiology: Implications for prevention and management Semin Thromb Hemost 28 2002 3 13
2. Stein PD, Patel KC, Kalra NK, Petrina M, Savarapu P, Furlong JW Jr, et al. Estimated incidence of acute pulmonary embolism in a community/ teaching general hospital. Chest. 2002;121:802-5.
3. M. Monreal, E. Lafoz, J. Ruiz, E. Valle, and A. Alastrue Upper extremity deep venous trombosis and pulmonary embolism: A prospective study Chest 99 1991 280 283
4. M. Monreal, A. Alastrue, M. Rull, X. Mira, J. Muxart, and R. Rosell, et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices-prophylaxis with a low molecular weight heparin (Fragmin) Thromb Haemost 75 1996 251 253
5. M. De Cicco, M. Matovic, L. Balestreri, G. Panarello, D. Fantin, and S. Morassut, et al. Central venous trombosis: An early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study Thromb Res 86 1997 101 103
6. J.J. Lokich, and B. Becker Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy Cancer 52 1983 1586 1589
7. C.J. Van Rooden, F.R. Rosendaal, R.M.Y. Barge, J.A. Van Oostayen, F.J.M. Van der Merr, and A.E. Meinders, et al. Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound Brit J Haematol 123 2003 507 512
8. M.E.T. Tesselaar, J. Ouwerkerk, M.A. Nooy, F.R. Rosendaal, and S. Osanto Risk factors for catheter-related thrombosis in cancer patients Eur J Cancer 40 2004 2253 2259
9. Bern MM, Lokich JJ, Wallach SR, Bothe A Jr, Benotti PN, Arkin CF, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med. 1990;112:423-8.
10. Kirkpatrick A, Rathbun S, Whitsett T, Raskob G. Prevention of central venous catheter-associated thrombosis: A meta-analysis. Am J Med 2007;120:901.e1-13.
11. C. Lewis, M. Allen, D. Burke, A. Cardella, S. Citron, and P. Cole, et al. Quality improvement guidelines for central venous access J Vasc Interv Radiol 14 2003 S231 S235
12. M.S. Cunningham, B. White, D. Hollywood, and J. O'Donnell Primary thromboprophylaxis for cancer patients with central venous catheters- a reappraisal of the evidence Br J Cancer 94 2006 189 194
13. H.V. Joffe, N. Kucher, V.F. Tapson, and S.Z. Goldhaber Deep Vein thrombosis (DVT) free Steering committee. Upper-extremity deep vein thrombosis: A prospective registry of 592 patiens Circulation 21 2004 1605 1611
14. W.D. Haire, T.G. Lynch, R.P. Lieberman, G.B. Lund, and J.A. Edney Utility of duplex ultrasound in the diagnosis of asymptomatic catheter-induced subclavian vein thrombosis J Ultrasound Med 10 1991 493 496
15. M. Verso, G. Agnelli, S. Bertoglio, F.C. Di Somma, F. Paoletti, and W. Ageno, et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: A double-blind, placebo-controlled, randomized study in cancer patients J Clin Oncol 23 2005 4057 4062
16. S. Couban, M. Goodyear, M. Burnell, S. Dolan, P. Wasi, and D. Bernes, et al. Randomized placebo-controlled study of low dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer J Clin Oncol 23 2005 4063 4069
17. M. Karthaus, A. Kretzschmar, H. Kröning, M. Biakhov, D. Irwin, and N. Marschner, et al. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: Final results of a double-blind, placebo-controlled phase III trial Ann Oncol 17 2006 289 296
18. D.C. Heaton, D.Y. Han, and A. Inder Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis Intern Med J 32 2002 84 88
19. R. Lecumberri, J. Feliu, and E. Roche Tromboembolia venosa en pacientes con cáncer Med Clin (Barc) 127 2006 22 32
20. M.R. Aboud Increased incidence of venous trombosis in patients with shortened activated partial thromboplastin times and low ratios for activated protein C resistanse Clin Lab Haem 23 2001 411 416
21. C. Legnani, S. Mattarozzi, M. Cini, B. Cosmi, E. Favaretto, and G. Palareti Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal Br J Haematol 134 2006 227 232
22. A. Tripodi, V. Chantarangkul, I. Martinelli, P. Bucciarelli, and P.M. Manucci A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism Blood 104 2004 3631 3634